The post Creative Eurecom wins the Innovation Prize 2019 from the newspaper ‘Courrier de l’Ouest’ first appeared on Creative Crossway.

Developing an effective treatment for respiratory infections, including those resistant to antibiotics, was the ambition of the ALIPEX collaborative program made up of three French SMEs: ALAXIA, CREATIVE EURECOM and DTF medical. The aim of this collaboration: to offer new generation inhaled treatment to patients with cystic fibrosis. The transportable device developed by CREATIVE EURECOM is a mini-factory for manufacturing medicines at home. Since the drug has a very short shelf life, the device allows it to be synthesized just before its administration. This equipment is the first in the world to allow the development of a drug in an extemporaneous manner.

Read more (french): electrondor.electroniques.biz/overview-2019/

The post Creative Eurecom Winner in the “Health” category at the Technical Day of Electronics, Paris June 27th, 2019 first appeared on Creative Crossway.

Creative Eurecom receives the Exemplary Achievement Award for its medical device that makes an extemporaneous drug available to cystic fibrosis patients directly to their homes.

The post Global Industrie Awards : Creative receives ‘Exemplary Achievement Award’ first appeared on Creative Crossway.